Boston Scientific appoints Isabel Newton as chief medical officer of its interventional oncology and embolization business

{
  "signal_id": "c8d74479-8847-4093-a5ea-7ac1bfa059e5",
  "signal_type": "news",
  "signal_subtype": "hires",
  "detected_at": "2026-02-03T12:48:18+00:00",
  "company": {
    "name": "Boston Scientific",
    "domain": "bostonscientific.com"
  },
  "data": {
    "url": "https://interventionalnews.com/boston-scientific-appoints-isabel-newton-as-chief-medical-officer-of-interventional-oncology-and-embolization-business",
    "title": "Boston Scientific appoints Isabel Newton as chief medical officer of its interventional oncology and embolization business",
    "contact": "Isabel Newton",
    "excerpt": "Boston Scientific appoints Isabel Newton as chief medical officer of its interventional oncology and embolization business.\n\nBoston Scientific has announced that Isabel Newton has been named chief medical officer of the company's interventional oncology (IO) and embolization business.\n\nThe company have stated that Newton joining Boston Scientific will support deeper engagement across the oncology landscape and strengthen its leadership in a rapidly evolving field.\n\nNewton is a board-certified diagnostic and interventional radiologist with deep clinical, academic, leadership and research experience in oncology. She previously served as chief of interventional radiology (IR) at the Veterans Affairs San Diego Health Care System in San Diego, USA and as a professor at University of California, San Diego Health, where she also held leadership roles in faculty development and wellness.\n\nHer research has focused on liver cancer, including cancer stem cells, cryoablation and immuno-oncology. Newton earned her doctor of medicine (MD) from Wake Forest School of Medicine, where she also completed a doctor of philosophy (PhD) in neurobiology and anatomy. She is the co-founder and chair of the Interventional Initiative, a nonprofit organisation that promotes minimally invasive, image-guided care.\n\nBoston Scientific's portfolio of cancer and embolization products includes the EMBOLD...",
    "summary": "Boston Scientific hires Isabel Newton as chief medical officer of interventional oncology and embolization business.",
    "category": "hires",
    "found_at": "2026-02-03T12:48:18Z",
    "planning": false,
    "image_url": "http://interventionalnews.com/wp-content/uploads/sites/13/2026/02/Isabel-Newton-Chief-Medical-Officer-Boston-Scientific-Interventional-Oncology-and-Embolization.jpg",
    "job_title": "chief medical officer of interventional oncology and embolization business",
    "confidence": 0.6486,
    "published_at": "2026-02-03T12:48:18Z",
    "article_sentence": "Boston Scientific appoints Isabel Newton as chief medical officer of its interventional oncology and embolization business."
  }
}

curl https://signals.autobound.ai/v1/signals/c8d74479-8847-4093-a5ea-7ac1bfa059e5 \
  -H "X-API-KEY: $AUTOBOUND_API_KEY"

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"bostonscientific.com","limit":20}'